ArticleCancers2021

Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors.

Sebastian Gulde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.